Press Releases

Application includes CheckMate -066, a clinical trial of Opdivo vs. dacarbazine chemotherapy in patients who had not received prior therapy. CheckMate -066 marked the first time that a PD-1 immune checkpoint inhibitor demonstrated survival in a...

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has agreed to sell €1.15 billion of senior unsecured notes: €575,000,000 in aggregate principal amount of 1.000% notes due 2025 and €575,000,000 in aggregate principal amount of 1.750% notes...

Reports Revenues of $4.0 Billion in the First Quarter Posts First Quarter GAAP and Non-GAAP EPS of $0.71 Achieves Key Data and Regulatory Milestones Across Portfolio Completes Strategic Transactions in Immuno-Oncology and Cardiovascular,...

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has commenced a cash tender offer for up to $400 million aggregate principal amount (the “tender cap”) of specified series of its outstanding debt. Pursuant to the tender offer,...

Huber Kältemaschinenbau shows Temperature Control Solutions for Laboratory and Process Industry At ACHEMA 2015 Huber Kältemaschinenbau presents a range of new and improved temperature control solutions from -125 to +425 °C for research laboratory and process...

The biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically detects both intact and C-terminal fragments of FGF23 in human serum and plasma. The FGF23 ELISA assay complements the...

Alfa Laval’s new WideGap100 gasketed plate heat exchanger combines an exceptionally high resistance to fouling and clogging with maximum heat transfer efficiency and compact size. WideGap100 is the smallest plate heat exchanger on the market that has been specially...